Zobrazeno 1 - 10
of 268
pro vyhledávání: '"J Peynet"'
Autor:
Jean-Philippe Kevorkian, J. Peynet, T. Meas, Marie Virally, Marie Laloi-Michelin, V. Giraudeaux, Pierre-Jean Guillausseau
Publikováno v:
European Journal of Internal Medicine. 20:197-200
Interest of statins in terms of morbid-mortality reduction in primary and secondary prevention in type 2 diabetic patients has broadly been proven in recent studies, while evidence for fibrates preventive effect is considerably weaker. HMGCoA reducta
Autor:
Dominique Bonnefont-Rousselot, Claudine Cosson, Nadjat Ouslimani, Meriem Mahrouf, Jean-Louis Beaudeux, Alain Legrand, J. Peynet
Publikováno v:
Metabolism. 56:308-313
Beyond its antihyperglycemic action, the antidiabetic oral drug metformin possesses antioxidant properties that may contribute to improve the cardiovascular deleterious effects of the diabetic disease. We explored whether metformin could modulate the
Autor:
C. Marchand, J. Peynet, Jean-Yves Artigou, A. Legrand, Dominique Bonnefont-Rousselot, Jean-Christophe Charniot, Khaled Zerhouni, M. Plotkine, N. Vignat
Publikováno v:
Free Radical Research. 41:424-431
This study aimed at evaluating OS in an amyotrophic quadricipital syndrome with cardiac impairment in a family of 80 members with a mutation in lamin A/C gene. Twelve patients had cardiac involvement (5 cardiac and skeletal muscles impairment). OS wa
Publikováno v:
Annales Pharmaceutiques Françaises. 64:373-381
Resume Les especes reactives de l’oxygene (ERO) et de l’azote (ERN) produites par les cellules ont ete longtemps vues comme des produits toxiques du metabolisme pouvant alterer les constituants lipidiques, proteiques ou le DNA de la cellule. Tout
Autor:
Raja Djelidi, J. Peynet, Patrice Thérond, Nadjat Ouslimani, M. Mahrouf, Martine Couturier, Jean-Louis Beaudeux, Alain Legrand
Publikováno v:
Biochemical Pharmacology. 72:176-183
Oxidative stress plays a major role in the pathogenesis and in the onset of macrovascular complications of diabetes. We previously reported that the antihyperglycaemic drug metformin was able to decrease significantly intracellular reactive oxygen sp
Autor:
J.-L. Beaudeux, J. Delattre, J. Peynet, Dominique Bonnefont-Rousselot, P. Thérond, A. Legrand
Publikováno v:
Immuno-analyse & Biologie Spécialisée. 21:144-150
Resume Les especes reactives de l'oxygene (ERO) et de l'azote (ERN), radicalaires ou non radicalaires, sont produites en permanence par les types cellulaires constituant la paroi vasculaire. Cette synthese est assuree par differents systemes enzymati
Autor:
J. Peynet, Nadjat Ouslimani, Jean-Louis Beaudeux, Patrice Thérond, Alain Legrand, Dominique Bonnefont-Rousselot
Publikováno v:
Metabolism. 54:829-834
Beyond its antidiabetic activity justifying its use in the treatment of the type 2 diabetes, metformin (MET [dimethylguanidine, Glucophage]) has been shown to exhibit antioxidant properties in vitro, which could contribute to limit the deleterious va
Publikováno v:
Annales Pharmaceutiques Françaises. 62:147-157
Chronic hyperglycemia in diabetes mellitus is an oxidative stress created by an imbalance of prooxidants over antioxidant defenses. The pathogenesis would involve several mechanisms including glucose autoxidation, protein glycation, the polyol pathwa
Autor:
J. Peynet, Dominique Bonnefont-Rousselot, S. Walrand, M.P. Vasson, Alain Legrand, Daniel Jore, Monique Gardès-Albert, B. Raji
Publikováno v:
Metabolism. 52:586-589
Metformin (dimethylbiguanide) is an antihyperglycemic agent used in type 2 diabetes. Beyond its action on glycemic control, metformin exhibits other intrinsic effects that could play a role in prevention against diabetes complications. Some studies t
Autor:
Patrice Thérond, Alain Legrand, Dominique Bonnefont-Rousselot, Jean-Louis Beaudeux, J. Peynet, J. Delattre
Publikováno v:
cclm. 37:939-948
The oxidative hypothesis of atherosclerosis classically implies a central role for low density lipoprotein (LDL) oxidation. However, new antiatherogenic properties have been recognized for high density lipoproteins (HDL), apart from their ability to